Type [qlco]
Hormone replacement therapy [topp]
Affect [menp]
Lipoprotein (a) [aapp, bacs]
homocysteine [aapp, bacs]
C-reactive protein level [lbpr]
postmenopausal [tmco]
Women [popg]
Background [cnce]
Result [ftcn]
studies [lbpr]
Evaluate [ftcn]
Effect [qlco]
Hormone replacement therapy [topp]
CARDIOVASCULAR [bdsy]
Risk [qlco]
controversies [socb]
This [euka]
Type [qlco]
treatment [ftcn]
Additional [ftcn]
risk factors [qnco]
Objective [inpr]
Objective [inpr]
Study [mnob]
To [qlco]
Evaluate [ftcn]
Effect [qlco]
Natural [ftcn]
Estrogens [horm, phsu, strd]
Taken [cnce]
Estrogens, Synthetic [orch, phsu]
Taken [cnce]
Orally [spco]
Concentrations [menp]
Lipoprotein (a) [aapp, bacs]
Lp(a) [aapp, bacs]
homocysteine [aapp, bacs]
C-reactive protein [aapp, imft]
Health [idcn]
Women [popg]
Early [tmco]
Post-menopausal Period [orgf]
Material [sbst]
Study [mnob]
Conduct [inbe]
Health [idcn]
Women [popg]
Average [qnco]
Age [orga]
Post-menopausal Period [orgf]
Assigned [ftcn]
depend [medd]
Type [qlco]
ROUTE [ftcn]
Administration [ocac]
Products [enty]
Group I [inpr]
N NOS [aapp, imft]
Administered [ftcn]
transdermal estrogen [horm, phsu, strd]
janssen [hcro]
Switzerland [geoa]
Progesterone [horm, phsu, strd]
Second [qnco]
Phase [tmco]
Cycle [tmco]
Group H [inpr]
N NOS [aapp, imft]
Administered [ftcn]
Oral [spco]
Hormones [horm]
Group [idcn]
III [inpr]
N NOS [aapp, imft]
Serving [qnco]
Control [grup]
included [ftcn]
Women [popg]
Take [hlca]
placebo [topp]
Form [qlco]
Patches [medd]
Group [idcn]
Therapeutic [topp]
Cycle [tmco]
Take [hlca]
days [tmco]
treatment [ftcn]
free [ftcn]
Interval [tmco]
month [tmco]
Result [ftcn]
treatment [ftcn]
Lp(a) [aapp, bacs]
homocysteine levels [lbpr]
Not [ftcn]
Different [qlco]
baseline [bodm]
ROUTE [ftcn]
Administration [ocac]
Estrogens [horm, phsu, strd]
placebo [topp]
Form [qlco]
Hormone replacement therapy [topp]
C-reactive protein [aapp, imft]
Concentration [menp]
Administration [ocac]
Analysis [lbpr]
Variance [qlco]
P NOS [aapp, imft]
C-reactive protein [aapp, imft]
Concentration [menp]
Values [qlco]
Increased [qnco]
Group [idcn]
Women [popg]
Using [ftcn]
Oral [spco]
Hormone replacement therapy [topp]
mg/L [qnco]
Group [idcn]
Women [popg]
Using [ftcn]
Oral [spco]
therapy [ftcn]
Cases [ftcn]
Increase [ftcn]
C-reactive protein [aapp, imft]
Concentration [menp]
Compared [acty]
Transdermal [ftcn]
Hormone replacement therapy [topp]
Group [idcn]
Chi [inpr]
P NOS [aapp, imft]
Observed [ftcn]
Conclusions [idcn]
observations [resa]
APPEAR [qlco]
Women [popg]
Early Stage [clas]
postmenopausal [tmco]
Normal concentration [fndg]
Initial [tmco]
Lp(a) [aapp, bacs]
homocysteine [aapp, bacs]
Form [qlco]
therapy [ftcn]
influential [idcn]
Values [qlco]
Parameters [fndg]
forms [qlco]
Hormone replacement therapy [topp]
Effect [qlco]
Change [ftcn]
C-reactive protein [aapp, imft]
Concentration [menp]
Increase [ftcn]
C-reactive protein [aapp, imft]
Values [qlco]
Using [ftcn]
Oral [spco]
Hormone replacement therapy [topp]
Observed [ftcn]
Effect [qlco]
Not [ftcn]
Observed [ftcn]
Transdermal [ftcn]
therapy [ftcn]
[c] [qnco]
Rights [qlco]
Reserve [acty]
